PREDICT 2: Personalized Responses to Dietary Composition Trial 2

NACompletedINTERVENTIONAL
Enrollment

1,139

Participants

Timeline

Start Date

June 10, 2019

Primary Completion Date

March 31, 2020

Study Completion Date

December 1, 2021

Conditions
DiabetesHeart DiseasesDiet HabitDiet ModificationMicrobial ColonizationHealthyObesityMetabolism
Interventions
OTHER

Dietary Intervention

To carry out an interventional dietary study using standardised meals to predict an individual's metabolic response to certain foods, using their gut microbiome, metabolic profile, and other measurable characteristics such as weight, sleep and exercise.

Trial Locations (1)

02118

Zoe US Inc., Boston

All Listed Sponsors
collaborator

Massachusetts General Hospital

OTHER

collaborator

Stanford University

OTHER

collaborator

King's College London

OTHER

collaborator

Tufts University

OTHER

lead

Zoe Global Limited

OTHER

NCT03983733 - PREDICT 2: Personalized Responses to Dietary Composition Trial 2 | Biotech Hunter | Biotech Hunter